Benlysta Continues to Gain Increased Market Share among U.S. Rheumatologists Six-Months Post-Launch, According to a Recent BioTrends Report.
Business Wire › December 12, 2011
Linked as:
Extract
Benlysta Continues to Gain Increased Market Share among U.S. Rheumatologists Six-Months Post-Launch, According to a Recent BioTrends Report.
EXTON, Pa. -- The LaunchTrends([R]): Benlysta Wave 3 report, which measures product uptake and commercial effectiveness at six months post launch, finds that over half of surveyed rheumatologists have initiated trial on Benlysta, up from 36% at three ...
See the full content of this document
Sponsored links
